Prophylactic Impella CP versus VA-ECMO in Patients Undergoing Complex High-Risk Indicated PCI

Table 3

Procedural characteristics and outcome.

Procedural Characteristics and Outcome	Impella CP (n = 27)	VA-ECMO (n = 14)	-value
Hemodynamic instability	1 (3.7%)	2 (14.3%)	0.22
Periprocedural mortality	0 (0%)	0 (0%)	1.00
Mortality at discharge	2 (7.4%)	2 (14.3%)	0.48
Mortality at 30 days	2 (7.4%)	2 (21.4%)	0.09
MACE at 30 days	10 (37.0%)	4 (21.4%)	0.59
Bleeding complications (BARC ≥3)	6 (22.2%)	1 (7.1%)	0.22
Grade 3A	4 (14.8%)	0 (0%)	0.12
Grade 3B	2 (7.4%)	1 (0%)	0.98
Access site related	2 (7.4%)	0 (0%)	0.30
Limb ischemia	0 (0%)	0 (0%)	1.00
Successful revascularization	25 (92.6%)	14 (100%)	0.47
Renal function postprocedural (increase ≥1 stage above baseline)	4 (14.8%)	3 (21%)	0.80
Hb prior to PCI (mmol/l)	7.7 (5.3–9.9 ± 1.2)	8.3 (6.9–9.8 ± 0.93)	0.13
Hb post PCI (mmol/l)	6.7 (5.2–8.6 ± 1.1)	6.4 (5.1–7.5 ± 0.76)	0.35
Transfer to ICU	5 (18.5%)	0 (0%)	0.06
Mean stay in ICU (days)	1 (1–1 ± 1)	0 (0–0 ± 0)	N/A
Mean stay in hospital (days)	3 (1–23 ± 4.76)	7 (2–28 ± 7.2)	0.23

ICU = intensive care unit; MACE = major adverse cardiovascular events; PCI = percutaneous coronary intervention.